Cervical Cancer Clinical Trials

Find Cervical Cancer Clinical Trials Near You

Improving Cervical Cancer Prevention Among Women Living With Chronic Conditions. Aim 3: Assess the Feasibility and Acceptability of the PINPOINT Intervention.

Status: Recruiting
Location: See location...
Intervention Type: Behavioral
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

Our overarching goal is to adapt and test the PINPOINT intervention -PatIent Navigation for the Prevention of CervIcal CaNcer inTervention. We will test the PINPOINT intervention among patients with high-risk profiles for cervical cancer who do not meet the recommended screening for cervical cancer.

Eligibility
Participation Requirements
Sex: Female
Minimum Age: 25
Healthy Volunteers: t
View:

‣ The following eligibility criteria will be used to determine inclusion into the study:

• Using the American Cancer Society (ACS) screening recommendations, adults aged over the age of 25 will be eligible

• Active UF Internal Medicine patient and has had an appointment in the last 2 months.

• Assigned sex at birth is female

• Have Obesity or Type 2 Diabetes

• Not currently pregnant (self-report)

• Have not given birth in the prior 12 weeks

• No previous history of cervical cancer

• No previous history of a hysterectomy

• Have not undergone cancer screening in the past 3 years or more

⁃ Reside in the UFHCI Catchment Area (Alachua, Baker, Bradford, Citrus, Clay, Columbia, Dixie, Gadsden, Gilchrist, Hamilton, Jefferson, Lafayette, Lake, Leon, Levy, Madison, Marion, Putnam, Sumter, Suwannee, Taylor, UnioF1n, or Wakulla County).

⁃ Have a mobile phone or access to a mobile phone that can be used to receive messages, or a valid email address.

⁃ Are not currently scheduled to receive cervical cancer screening via clinician sampling (pap smear).

Locations
United States
Florida
UF Health Internal Medicine
RECRUITING
Gainesville
Contact Information
Primary
Rahma Mkuu, PhD
rmkuu@ufl.edu
(352) 294-8419
Backup
Daniela Rivero-Mendoza, MS.
crivero@ufl.edu
Time Frame
Start Date: 2026-08-30
Estimated Completion Date: 2028-03-31
Participants
Target number of participants: 20
Treatments
Experimental: Intervention
PINPOINT intervention arm will entail assigning patients to a patient navigator to assist them with screening reminders and address any barriers they have to screening, education on cervical cancer screening, and patients will also be offered the opportunity to self-collect their sample for cervical cancer screening.
No_intervention: Control Arm
No intervention arm, patients will receive reminders for screening according to current clinical practice
Related Therapeutic Areas
Sponsors
Leads: University of Florida
Collaborators: National Cancer Institute (NCI)

This content was sourced from clinicaltrials.gov